Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in rats
Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in rats
复制标题
格列本脲增强大鼠实验性中风后延迟低温的作用
DOI:
10.1016/j.brainres.2016.04.067
复制
发表时间:
2016-07-15
期刊:
影响因子:
2.9
通讯作者:
Pan, Su-Yue
中科院分区:
文献类型:
--
作者:
Wu, Zhou;Zhu, Shu-Zhen;Pan, Su-Yue
In order to evaluate whether glibenclamide can extend the therapeutic window during which induced hypothermia can protect against stroke, we subjected adult male Sprague-Dawley rats to middle cerebral artery occlusion (MCAO). We first verified the protective effects of hypothermia induced at 0, 2, 4 or 6 h after MCAO onset, and then we assessed the effects of the combination of glibenclamide and hypothermia at 6, 8 or 10 h after MCAO onset. At 24 h after MCAO, we assessed brain edema, infarct volume, modified neurological severity score, Evans Blue leakage and expression of Sulfonylurea receptor 1 (SUR1) protein and pro-inflammatory factors. No protective effects were observed when hypothermia was induced too long after MCAO. At 6 h after MCAO onset, hypothermia alone failed to decrease cerebral edema and infarct volume, but the combination of glibenclamide and hypothermia decreased both. The combination also improved neurological outcome, ameliorated blood-brain barrier damage and decreased levels of COX-2, TNF-alpha and IL-1 beta. These results suggest that glibenclamide enhances and extends the therapeutic effects of delayed hypothermia against ischemia stroke, potentially by ameliorating blood-brain barrier damage and declining levels of pro-inflammatory factors. (c) 2016 Elsevier B.V. All rights reserved.